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Background: Alterations in the fecal bacterial flora occur in inflammatory bowel disease (IBD). We examined the
abundance and diversity of Clostridium leptum group, an important group of carbohydrate-fermenting bacteria, in
the feces of patients with IBD and compared them with healthy controls.
Methods: Seventeen healthy controls (HC), 20 patients with Crohn’s disease (CD) and 22 patients with ulcerative
colitis (UC) participated in the study. DNA extracted from fecal samples was amplified by PCR targeting 16S rRNA
gene sequences specific to C. leptum group. The PCR product was subjected to temporal temperature gradient
electrophoresis (TTGE) and the number and position of individual bands were noted and diversity was estimated.
The identity of bands at different positions was confirmed by cloning and sequencing. Real time quantitative PCR
with Mesa Green, targeted at specific 16S rRNA gene sequences, was used to quantitate C. leptum group and its
most prominent constituent, Faecalibacterium prausnitzii.
Results: Twenty five different operational taxonomic units (OTUs, equivalent to species) were identified constituting
the C. leptum group in these participants. Their sequences were deposited in GenBank [accession numbers
GQ465348 to GQ465370]. OTU number was significantly reduced in CD (7.7±3.7, mean±SD) and UC (9.0±3.0)
compared to HC (11.9±2.2) (P=0.0005). The Simpson D index of alpha diversity was not significantly different
between the three groups. Total numbers of C. leptum group bacteria and F. prausnitzii were reduced in both CD
and UC compared to HC (P=0.0036 and P<0.0001 respectively). Disease activity did not influence numbers of
C. leptum or F. prausnitzii in patients with CD or UC.
Conclusion: C. leptum numbers and diversity were significantly reduced in both CD and UC suggesting that
alterations noted were not specific to one disease. This could contribute to reduced short chain fatty acid
production in IBD.
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The Clostridium leptum group of bacteria is one of the
dominant groups of fecal bacteria in adult humans, consti-
tuting 16-25% of the fecal microbiota [1,2]. This group, also
called Clostridial cluster IV, includes Faecalibacterium
prausnitzii and certain species of Eubacterium and
Ruminococcus [3]. Members of this group synergize
with other intestinal microbiota to ferment unabsorbed
dietary carbohydrate, producing short chain fatty acids
of which butyrate is the major energy source for the
colonic epithelium and profoundly influences intestinal
epithelial function. F. prausnitzii, the most abundant
member of this group, is a major producer of butyrate
through carbohydrate fermentation [4]. It has acquired
special status because of its association with anti-
inflammatory effects in the gastrointestinal tract [5].
Any alteration in the composition of the gut microbiota
that changes the microbial balance is likely to have
repercussions on human health.
Inflammatory bowel diseases (IBD), comprising the
two diseases ulcerative colitis (UC) and Crohn’s disease
(CD) are thought to result from disordered innate
immune reactions to luminal microbiota in individuals
with the appropriate genetic disposition [6]. A number
of studies indicate that microbiota alterations, termed
dysbiosis, are common in IBD [7-14]. These alterations
include reduction of total microbial diversity, increased
numbers of Enterobacteriaceae, increased abundance of
Bacteroides-Prevotella, increase or decrease in bifido-
bacteria, and decrease in the numbers of Firmicutes
(especially Clostridium coccoides-Eubacterium rectale
and F. prausnitzii). Most of the changes described have
been in patients with active CD. An earlier study suggested
that F. prausnitzii numbers were decreased in active CD
but increased in active UC [8]. It is not known whether
these changes are specific to CD, or whether they reflect
changes that are more universally present in patients with
IBD. It is also not known whether these changes in the
microbiota persist in quiescent IBD.
In the present study we investigated the species diversity
of the C. leptum group of bacteria in the feces of healthy
individuals and patients with IBD in remission using
amplification of the 16S rRNA gene followed by
temperature gradient electrophoresis. We also quantitated
C. leptum group and F. prausnitzii using real time PCR




Seventeen healthy control (HC) volunteers, 20 patients
with CD and 22 patients with UC participated in this
study. Participants were identified in the IBD clinic of the
department, informed about the purpose of the study, andprovided written consent. CD and UC were diagnosed on
the basis of Asian consensus criteria for diagnosis of these
diseases [15]. Disease activity status was assessed by the
Crohn’s disease activity index and Truelove-Witts scoring
system respectively [16,17]. Controls were identified
from apparently healthy individuals visiting the general
medical clinics of the hospital for routine health
checkup. Participants who had taken antibiotics within
the last three months were excluded. Fresh samples of
feces were collected and transported within three hours
to the laboratory, where they were stored in aliquots at
-20°C for processing in batches. The protocol was
approved by the institutional ethics committee of the
Christian Medical College, Vellore.
DNA extraction and polymerase chain reaction
amplification
Total DNA was extracted from ~250 mg (wet weight)
of fecal sample using the QIAamp DNA stool mini kit
(Qiagen, Hilden, Germany) as per manufacturer’s
instructions. The DNA was eluted in a final volume of
200 μL and stored at -20°C. The concentration and
integrity of the nucleic acids were determined by
electrophoresis on 1% agarose gel containing ethidium
bromide. C. leptum group DNA sequences were amplified
using primers that targeted sequences in the 16S rRNA
gene specific to that group. The primers that were
used were sg-Clept-F (Forward 50-GCACAAGCAGTG
GAGT-30) and Clept-GC-R3 (Reverse with GC Clamp
50-CTTCCTCCGTTTTGTCA-30) [18]. Polymerase chain
reaction (PCR) was performed in a reaction volume of
20 μl containing 1X PCR buffer, 2.5 mM MgCl2, 200 mM
each dNTP, 250 nmol of both forward and reverse
primers, 2.5 U of Jumpstart Taq polymerase (Sigma Aldrich
Co, St. Louis, MO, USA), and approximately 10 ng of DNA
template. Samples were amplified in a MJ Mini thermal
cycler (Bio-Rad, Hercules, CA, USA) using the following
program: 95°C for 1 minutes, 30 cycles of 95°C for
30 seconds, 56°C for 30 seconds, 72°C for 30 seconds,
and finally 72°C for 10 minutes. PCR products were
analyzed by electrophoresis on 2% agarose gel containing
ethidium bromide to check their size (239 bp) and estimate
their concentration.
Temporal temperature gradient electrophoresis
We subjected the PCR product to temporal temperature
gradient electrophoresis (TTGE) for sequence-specific
separation. Electrophoresis was performed in 1 mm thick,
16×16 cm polyacrylamide gel (7% wt/vol acrylamide/Bis,
7 M urea, 1.25X TAE, and, respectively, 55 ml and 550 μl
of TEMED and 10% ammonium persulfate) using 25 litres
of 1.25X TAE as the electrophoresis buffer in a TTGE
detection system (CBS Scientific Co, San Diego, CA, USA).
The TTGE conditions included electrophoresis at 50 mA
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of 0.3°C/h. To improve resolution, the voltage was set at
20 mA for 15 min at the beginning of each run. Each well
was loaded with 100 to 200 ng of amplified DNA plus an
equal volume of 2X gel loading dye (0.05% bromophenol
blue, 0.05% xylene cyanol, and 70% glycerol). Gels were
stained in the dark by immersion for 15 min in a solution
of ethidium bromide stain and were read using the
Chemicapture software in a Chemi-Smart imaging system
(Vilber Lourmat, Marne-la-Vallee, France). Each sample
analyzed in this study was run in duplicate and consensus
data compiled. In order to determine variations between
PCR and TTGE, DNA samples from a subset of subjects
were amplified in duplicate by PCR and TTGE was run
again on another day. These samples were compared to
each other by TTGE on the same gel, and PCR amplicons
were run again on a different day and gel to determine
gel-to-gel variation. Composite data sets for group-
specific TTGE profiles were generated and numerical band
matching character tables produced. The BioDiversity Pro
statistical package (version 2; Scottish Association for
Marine Science, http://www.sams.ac.uk) was used for prin-
cipal component analysis. The SDR software (version 4.1.2,
Pisces Conservation Ltd., www.pisces-conservation.com)
was used for diversity analysis.
Cloning of the PCR products and clone library analysis
Cloning PCR was performed using the same primers but
without the GC clamp in the reverse primer. The
purified PCR products were cloned into E. coli DH5α using
the pCR™ 2.1-TOPOR vector (TOPO TA cloning kit,
Invitrogen, Carlsbad, CA, USA). Forty five recombinant
clones were randomly selected for analysis. The plasmids
were purified (Purelink Plasmid Miniprep Kit, Invitrogen,
Carlsbad, CA, USA) and were used as templates for ampli-
fication of the 239 bp C. leptum group-specific 16S rRNA
gene fragment with the above mentioned primers without
GC clamp for reverse primers. The amplicons were
subjected to TTGE analysis. If two clones migrated to the
same distance, only one clone was selected for sequencing.
All clones which migrated to different distances were
selected for sequencing. A total of 23 clones were sequenced
using M13 forward primer (Bioserve Biotechnologies,
Hyderabad, India). Clones which were sequenced were run
on the TTGE analysis along with one sample (individual A)
to identify the phylogeny of individual bands on TTGE.
Sequence analysis
Sequences from our clones and sequences retrieved
from the GenBank database were taken to a length of
239 bp corresponding to the C. leptum amplicon length.
Sequences obtained in our study were aligned with the
sequences in the Ribosomal Database Project (release 9)
database to determine their closest relatives. Sequenceswere aligned separately using ClustalX 2.0.9 and analyzed
using PHYLIP version 3.68 after 1000 bootstrapping opera-
tions. The distance matrices on these datasets were created
using DNADIST (PHYLIP version 3.68) and the sequences
were subsequently clustered using NEIGHBOUR (PHYLIP
version 3.68). The tree files from NEIGHBOUR were
applied with CONSENSE (PHYLIP version 3.68) and
the consensus tree was viewed using PHYLODRAW.
Real time PCR assays for C. leptum group and
Faecalibacterium prausnitzii
Real-time quantitative (q) PCR was performed using a
Chromo4 four color real time PCR detection system with
Opticon Monitor 3 software (Bio-Rad, Hercules, USA).
Amplification and detection were carried out in 96-well
plates with Mesa Green qPCR Master Mix (Eurogentec
SA, Liege, Belgium). Primers were directed at 16S rRNA
sequences specific to C. leptum and F. prausnitzii. The
primers used to quantify C. leptum were the same as those
used for TTGE but without the GC clamp in the reverse
primer. The primers used to quantify F. prausnitzii were
as follows: Forward primer 50-GGAGGATTGACCCCTT
CAGT-30 and reverse primer 50-CTGGTCCCGAAGAAA
CACAT-30 [19]. Primers were synthesized and purchased
from Sigma Aldrich Chemicals (Bangalore, India). Each
reaction was done in duplicate in a final volume of 20 μL.
Amplifications were performed as follows: 95°C for
5 minutes, to denature DNA and followed by 40 cycles of
94°C for 10 seconds, 58°C for 30 seconds and 72°C for
30 seconds. The final extension step at 72°C for 10 min
was followed by a melting curve analysis which was
performed by increasing the temperature from 40 to 95°C,
with a raise in temperature by 1°C every 10 sec with a plate
read step to read the fluorescent signal. DNA copy was
expressed as copy number per gram of feces and samples
were run in real time PCR along with plasmid standards.
Statistical analysis
Normally distributed data was compared using ANOVA
with post-hoc Bonferroni tests, while data that was not dis-
tributed normally was compared using the Kruskal-Wallis
test with post-hoc Dunn tests.
Results
Twenty CD patients (6 female) with mean (SD) age of
31.2 (14.1) years were recruited. They had disease
duration ranging from 6 months to three years. Eleven
of the patients had a CDAI score of 150 or more, and
were categorized as having active CD. Twenty two UC
patients (9 female) with mean (SD) age 38.4 (11.3) years
were recruited. They had disease duration ranging from
six months to eight years. Nine of the UC patients had a
UCAI score of 3 or more, and were categorized as having
active UC. None of the patients was on treatment with
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aminosalicylates. Seven of the CD patients and six of the
UC patients also received azathioprine. Four of the CD
patients had undergone surgery earlier. None of the
patients had colonic lavage or colonoscopy within the
month prior to stool collection. Seventeen HC (8 female)
with mean (SD) age 31.1 (13.8) years were recruited.
Clone library analysis of C. leptum cluster and
identification of TTGE bands
A total of 45 clones were obtained which were amplified
and run on TTGE. Only clones which differed in migrating
position were selected for sequencing. Thus 25 clones were
sequenced. The analysis showed that our cloned sequences
had high similarity with known sequences available in
GenBank. Most of the clones that we isolated belonged to
genus Faecalibacterium (65%), Subdoligranulum (8%) and
Ruminococcus (4%). The recombinant clones in the library
were amplified using primers sg-Clept-F and sg-Clept-GC-
R3, and the amplified products were subjected to TTGE in
order to generate the identity of each of the TTGE bands.
Nucleotide sequence accession numbers
The sequences generated in this study were deposited
in the GenBank database under accession numbers
[GQ465348 to GQ465370].
TTGE profiles for C. leptum group
The PCR amplicons were run on TTGE (Figure 1), the
image documented and a binary data matrix created by
the presence or absence of bands at a specific location.
Each band was considered as an operational taxonomic
unit (OTU) equivalent to a species. Totally we observed
25 species for the C. leptum group by TTGE.
Multivariate analysis of the TTGE profiles
Principal component analysis (PCA) of the TTGE profiles
obtained from the healthy subjects and IBD patientsFigure 1 TTGE gel showing bands migrating at different positions. Ea
individual participant. Details of the TTGE conditions are provided in the tedemonstrated that the bacterial community profiles were
dissimilar by the first and the second principal component
(x and y axes on the PCA plot, respectively) (Figure 2).
HC were predominantly grouped to the right side of
PCA1 whereas CD and UC were more likely to cluster
on the left side in PCA1, suggesting that the microbial
communities of the healthy individuals shared some
characteristics that differentiated them from IBD patients.
CD and UC appeared to cluster together in the plot.
Cluster analysis of the TTGE data
The TTGE binary data, that is the presence or absence
of bands, was analyzed by cluster analysis using Bray’s
cluster index (Figure 3). In this analysis all sample data
were analyzed together, including HC, CD and UC.
Compared to the healthy controls, most of the CD and
UC patients showed higher dissimilarity in the dendro-
gram, which again confirmed the observation of PCA.
At cut-off 70% below that similarity, controls and IBD
groups were clearly differentiated.
Diversity indices based on TTGE profile
The number of C. leptum group species (Figure 4) was
significantly less in CD and UC compared to HC. HC
had a mean (SD) of 11.9 (2.2) OTUs in the C. leptum
group compared to 7.7 (3.7) in CD patients and 9.0 (3.0)
in UC patients (P<0.001 HC vs. CD; P<0.05 HC vs. UC;
P-NS CD vs. UC). The Simpson’s D index of alpha diversity
was 19.65 for HC compared to 17.56 for CD and 17.51 for
UC. The difference between HC and CD and UC was not
statistically significant.
Quantitation of C. leptum group and Faecalibacterium
prausnitzii in feces
The count of Clostridium leptum group bacteria in feces
was significantly reduced in CD and UC compared to
healthy controls (HC vs. CD P<0.01; HC vs. UC P<0.05)
(Figure 5A). Faecalibacterium prausnitzii counts werech lane depicts fecal DNA amplified using the Clept primers from an
xt.
Figure 2 Principal components analysis of fecal C. leptum group bacterial communities. C. leptum species dominantly represented in
healthy controls (HC, blue) tend to cluster to the right side of the plot, while those species dominant in Crohn’s disease (CD, green) and
ulcerative colitis (UC, turqoise) patients tend to cluster to the left of the plot.
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to HC (HC vs. CD P<0.001; healthy vs. UC P<0.001)
(Figure 5B).
Microbiota composition: comparison of active IBD with
disease remission
Comparison of C. leptum group and F. prausnitzii
quantitation between IBD patients with active disease
(CDAI ≥ 150 or UCAI ≥ 3) and those in clinical remission
(CDAI < 150 or UCAI < 3) did not show any quantitative
differences between the two groups (Figure 6). There was
no correlation of microbial community abundance with
duration of diarrhea.
Discussion
This study, using TTGE to study diversity of C. leptum
group in IBD patients, provides important information
regarding the colonic microbiota in IBD that will
augment the existing knowledge in this area. The study
shows that there was a reduction of absolute number as
well as species number per individual of the C. leptum
group in both UC and CD. The reduction in numbers
was explained to a large extent by the reduction in F.
prausnitzii, and this alteration was present in both
quiescent and active IBD. C. leptum group bacteria from
IBD patients clustered separately from bacteria present
in the healthy controls. Lastly the study provides, for the
first time, a catalog of the C. leptum group of bacteria in
the feces of healthy adult humans in India. The presentstudy focused solely on the C. leptum group and F.
prausnitzii and did not attempt to determine changes in
other microbial communities in IBD.
The utilization of culture-independent methods of
analysis has significantly enhanced our ability to assess
the contribution made by the gut microbiota to human
health. In this study, we amplified portions of the 16S
rRNA gene that are specific for the C. leptum group of
bacteria and used TTGE to identify the numbers of
species present in in each individual. TTGE is a very
sensitive technique to detect single nucleotide changes
in DNA. The primer set used is able to detect species of
the C. leptum group including C. leptum, Eubacterium
plautii, Clostridium viride, and Ruminococcus albus
strains which are present in small proportions in human
fecal samples [19]. TTGE revealed multiple bands, which
were cloned and sequenced to reveal at least 25 different
species or OTU belonging to this group. The clone
library that we generated, as well as the real time PCR
data, showed that F. prausnitzii was the major constituent
(approximately 65%) of this bacterial group. The presence
of Subdoligranulum variabile as a part of this bacterial
group in our participants is consistent with other
reports [20].
Healthy controls in the present study had a mean of 12
OTUs of the C. leptum group in feces, and this number
was significantly reduced in CD and UC patients. However,
using the Simpson D index, we did not find any alter-
ation in alpha diversity between HC, UC and CD.
Figure 3 Bray Curtis cluster analysis of fecal C. leptum group communities. Bacteria from Crohn’s disease (CD) and ulcerative colitis (UC)
patients appeared to have higher degrees of dissimilarity to each other than bacteria from healthy controls (HC).
Figure 4 Number of C. leptum species in the feces of
individuals in the three groups. Values shown are mean (SEM).
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C. leptum, C. coccoides, and certain other Firmicutes was
reduced in patients with CD. Their conclusions were
based on the analysis of a limited number of clones
derived from fecal microbiota of these patients. Other
investigators have reported that C. leptum diversity was
reduced in patients with CD [21]. Principal components
analysis showed that C. leptum from most of the control
subjects clustered discretely to one side whereas C. leptum
from CD and UC patients clustered separately. This obser-
vation needs to be confirmed in more rigorous studies.
Relative abundance of the targeted microbial communities
was evaluated using real time PCR in which the specific
abundance was expressed relative to amplification of
universal bacterial domain sequences of 16S rRNA,
i.e. expressed relative to total bacteria. The abundance of
Figure 5 Abundance of C. leptum group bacteria (A) and F.
prausnitzii (B). Bacterial abundance in HC, CD and UC, is expressed
as mean (SEM) copy number of 16S rRNA gene/g feces.
Figure 6 Abundance of C. leptum group bacteria and F.
prausnitzii in active and quiescent IBD. Values shown are mean
(SEM) of 16S rRNA gene copy number per g feces in patients with
CD and UC with quiescent and active disease.
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significantly reduced in both CD and UC compared to
HC. Similar findings have been reported earlier [14,21]. In
the present study, there was no significant difference in
fecal counts of either C. leptum group or F. prausnitzii
between patients with active IBD and those with quiescent
IBD (i.e. those who were in remission). There is little
literature on this aspect; however one earlier study
suggested that the differences in abundance of C. leptum
and F. prausnitzii occurred in active IBD but not in IBD
in remission [9].
The significance of these findings can be interpreted
varyingly. C. leptum group (cluster IV) is one of the
dominant populations of the human fecal microflora
[3,22] and contains a large number of butyrate-producing
bacteria. It is not known whether the changes in C. leptum
number and diversity antedate the development of IBD.
However, by showing that changes occur in the same
direction in both CD and UC, we can conclude that thesechanges are not specific to either disease. The alterations
were of greater magnitude in CD patients compared to
UC patients. We do not have an explanation for this
observation. It was also noted in our study that the changes
were noted in both active and quiescent IBD, suggesting
that the changes were not secondary to gut inflammation
and ulceration and presence of pus and blood in the lumen.
Probiotics used in IBD are typically a mixture of lactobacilli
and bifidobacteria. Species belonging to the C. leptum
group (esp. F. prausnitzii) are also now considered as
anti-inflammatory commensal bacteria. Loss of butyrate,
which has an anti-inflammatory activity [23], may result
in greater inflammation in the colon.
Our data shows decreased diversity of the C. leptum
group in IBD patients. Increased species diversity is an
indication of a robust microsystem. Loss of this diversity
is likely to impact on gut health, even if it is not the
primary phenomenon driving gut inflammation. The
intake of prebiotic substrates like inulin can increase
both bifidobacteria and F. prausnitzii in the human gut,
and this may be one possible intervention to consider in
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that treatment of IBD patients with butyrate producing
bacteria such as the C. leptum group bacteria will emerge
as another therapeutic option in these patients [25].
Conclusions
Bacteria belonging to the C. leptum group, including the
dominant constituent F. prausnitzii, are significantly
reduced in the fecal microbiota of patients with Crohn’s
disease and ulcerative colitis. There is a reduction in
both the number of species and the absolute number of
bacteria in each individual compared to healthy controls.
The reduction is found both in active disease and during
disease remission, indicating that it is not temporally
related to alterations in the intestinal milieu during
flares of inflammation. These changes are likely to be
significant in the context of the dysbiosis that occurs in
patients with IBD.
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